BS
22/02/2021
1
$10.25
8.01%
- COMMENTARY
The 2020 result headline was pre-announced while underlying trends were slightly better than UBS expected.
While the -US$1.5bn loss justifies a -40% underperformance in the share price over the last 12 months, the broker believes the provisions taken by QBE are for currently unreported claims.
With the earnings hit and negative news flow now captured in the share price UBS upgrades to Buy from Neutral. Target is raised to $10.25 from $9.00.
Ann: Market release on QBE's FY20 Results, page-7
Add QBE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.39 |
Change
0.110(0.68%) |
Mkt cap ! $24.67B | |||
| Open | High | Low | Value | Volume |
| $16.11 | $16.47 | $16.07 | $55.25M | 3.374M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14975 | $16.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.40 | 5185 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| QBE (ASX) Chart |